Confirm pleural chyle biochemically, distinguish it from pseudochylothorax, find traumatic or non-traumatic causes, protect nutrition and immunity, and escalate a persistent leak to specialist lymphatic intervention.
The thoracic duct carries absorbed long-chain dietary lipid and lymph from much of the body to the venous circulation. A leak below the usual mid-thoracic crossing tends to produce a right-sided effusion and a leak above it tends to be left-sided, but anatomical variation makes this an unreliable diagnostic rule. Bilateral collections occur. Chyle may be creamy, serous or blood-stained, particularly during fasting or after surgery.
The diagnostic task has three parts: prove that the fluid is chyle, decide whether the mechanism is duct disruption or impaired lymphatic flow, and establish the physiological cost of the leak. A postoperative onset is often clear; an apparently spontaneous chylothorax needs cross-sectional imaging and a deliberate malignancy and central-vein review. Lymphatic imaging is reserved for unresolved anatomy or to plan intervention.
Management is individualised because evidence is limited and output varies with oral intake. Conservative nutritional measures can reduce lymph flow while the injury heals, but prolonged restriction or drainage can create serious malnutrition and immune depletion. An MDT should set a time-limited plan with escalation criteria rather than continuing ineffective conservative care indefinitely.
Thoracic surgery, central venous procedures and blunt or penetrating trauma can disrupt the duct or its tributaries and leak chyle into pleura.
Lymphoma and other mediastinal cancers obstruct or invade lymphatic pathways and are important non-traumatic causes in adults.
Congenital lymphatic abnormalities and rare diffuse lymphatic diseases can cause spontaneous or recurrent chyle leakage, with the final risk shaped by exposure and individual susceptibility.
Central venous thrombosis, cirrhosis and other causes of impaired thoracic lymph drainage can produce chylous effusion without direct duct rupture.
Damage or obstruction raises pressure within the thoracic duct and allows intestinal lymph to escape through a defect.
Triglyceride-rich chyle collects in one or both pleural spaces, with appearance influenced by recent dietary fat intake and fasting.
Increasing fluid compresses adjacent lung, reduces ventilated volume and causes breathlessness or hypoxaemia according to the patient's reserve.
Persistent drainage removes fat, protein, electrolytes, immunoglobulins and lymphocytes, impairing nutrition and immune competence, thereby altering ventilation, gas transfer or respiratory mechanics.
New pleural drainage that increases or becomes creamy after enteral feeding following oesophagectomy, mediastinal surgery, cardiac surgery or neck dissection is highly suggestive. Record the operation, side, daily volume and relation to feeding.
Progressive breathlessness with a unilateral or bilateral effusion, lymphadenopathy, weight loss, venous thrombosis or features of a lymphatic disorder should prompt investigation for lymphoma, metastatic malignancy and impaired central lymphatic drainage.
Tachypnoea, hypoxaemia, inability to lie flat or mediastinal displacement from a large collection requires urgent ultrasound-guided therapeutic drainage assessment, irrespective of whether lipid testing has returned.
Weight loss, weakness, low albumin, electrolyte disturbance and lymphopenia can emerge during a sustained high-output leak. Recurrent infection may reflect both the underlying condition and loss of immune components.
A chronic calcified or thickened pleura with rheumatoid disease or previous tuberculosis favours a cholesterol-rich pseudochylous collection; it is a different process and thoracic-duct intervention is not its treatment.
A long-standing inflammatory effusion rich in cholesterol can also appear milky; lipid analysis and crystals distinguish it from true chyle.
Turbid pus may resemble chyle, but infection features, pleural pH, microscopy and separation after centrifugation support empyema.
Blood-stained pleural fluid after trauma or surgery requires fluid haematocrit assessment and urgent consideration of active bleeding.
Malignant or inflammatory serous fluid may be cloudy without chylomicrons; pleural biochemistry and cytology identify the broader process.
A large or recurrent collection restricts lung expansion and can worsen oxygenation, particularly after thoracic surgery or in underlying lung disease.
Continuing chyle loss depletes calories, essential fats and protein, delaying wound healing and recovery, with severity determined by its extent and the patient's underlying reserve.
Loss of lymphocytes and immunoglobulins weakens host defence and increases vulnerability to infection during prolonged leakage.
High-output loss can cause dehydration and biochemical abnormalities, especially when repeated drainage is needed, creating an additional need for recognition and targeted treatment.
Failure of the leak to close may require lymphatic imaging, embolisation or surgery and prolong hospitalisation.
Fasting, low oral intake or admixture with blood can make genuine chyle non-milky. Conversely, empyema and cholesterol-rich fluid may look creamy without containing chylomicrons.
Medium-chain triglycerides are absorbed mainly into portal blood rather than packaged as intestinal chylomicrons, which can reduce but not abolish thoracic-duct flow.
Among non-traumatic causes, lymphoma is particularly important; cytology alone may be insufficient, so imaging, flow cytometry or tissue should be selected from the clinical picture.
A clear radiograph while litres of nutrient-rich fluid leave the body is not recovery. Output, replacement needs and the probability of spontaneous closure must drive decisions.
Diagnosing chylothorax from colour without pleural lipid testing or chylomicron confirmation when needed.
Confusing pseudochylothorax with a thoracic-duct leak and sending the patient for inappropriate lymphatic intervention.
Continuing unrestricted chest drainage while failing to count calories, lymphocytes, electrolytes and protein loss.
Using an improvised fat-free diet without a specialist dietitian or a defined duration and nutritional replacement plan.
Repeatedly extending conservative care despite persistent clinically important output and a worsening nutritional trajectory.
Your practice draft is saved in this browser.
Five days after oesophagectomy, a patient's chest drain becomes cloudy after enteral feeding. Pleural triglyceride is 1.5 mmol/L and cholesterol is low. Which interpretation is most appropriate?
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.
Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes
Evidence is limited and it must not delay embolisation or surgery when loss persists. Monitor glucose, gastrointestinal effects, gallbladder risk, pulse and relevant interactions; dosing varies with route, organ function and local experience.